AAAAAA
Results:
1-7
|
Results: 7
Authors:
Sandborn, WJ
Loftus, EV
Colombel, JF
Fleming, KA
Seibold, F
Homburger, HA
Sendid, T
Chapman, RW
Tremaine, WJ
Kaul, DK
Wallace, J
Harmsen, WS
Zinsmeister, AR
Targan, SR
Citation: Wj. Sandborn et al., Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease, INFLAMM B D, 7(3), 2001, pp. 192-201
Authors:
Gow, PJ
Fleming, KA
Chapman, RW
Citation: Pj. Gow et al., Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease?, J HEPATOL, 34(4), 2001, pp. 631-635
Authors:
Fleming, KA
Boberg, KM
Glaumann, H
Bergquist, A
Smith, D
Clausen, OPF
Citation: Ka. Fleming et al., Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis, J HEPATOL, 34(3), 2001, pp. 360-365
Authors:
Mitchell, SA
Grove, J
Spurkland, A
Boberg, KM
Fleming, KA
Day, CP
Schrumpf, E
Chapman, RW
Citation: Sa. Mitchell et al., Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis, GUT, 49(2), 2001, pp. 288-294
Authors:
Mitchell, SA
Bansi, DS
Hunt, N
von Bergmann, K
Fleming, KA
Chapman, RW
Citation: Sa. Mitchell et al., A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis, GASTROENTY, 121(4), 2001, pp. 900-907
Authors:
Fleming, KA
Citation: Ka. Fleming, The anatomy of the normal liver and the hepatic lymphocyte, T LYMPHOCYTES IN THE LIVER, 1999, pp. 1-13
Authors:
Brittenham, GM
Fleming, KA
Templeton, DM
Olivieri, NF
Citation: Gm. Brittenham et al., Iron chelation with oral deferiprone in patients with thalassemia - Reply, N ENG J MED, 339(23), 1998, pp. 1713-1714
Risultati:
1-7
|